We are live on ! Find out more
BM

Bridger Management Portfolio holdings

AUM $128M
1-Year Est. Return 9.54%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.07B
AUM Growth
+$671K
Cap. Flow
-$58.6M
Cap. Flow %
-5.47%
Top 10 Hldgs %
49%
Holding
50
New
8
Increased
6
Reduced
10
Closed
6

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$43.2M
2
NVRO
NEVRO CORP.
NVRO
+$13.6M
3
PSPC.U
Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant
PSPC.U
+$12.6M
4
LIVN icon
LivaNova
LIVN
+$10.4M
5
CLVT icon
Clarivate
CLVT
+$9.91M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$33M
2
MSFT icon
Microsoft
MSFT
+$26.9M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$16.9M
4
FCNCA icon
First Citizens BancShares
FCNCA
+$16.7M
5
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$15.1M

Sector Composition

Rank Sector Weight
1 Healthcare 40.41%
2 Technology 21.62%
3 Consumer Discretionary 18.81%
4 Communication Services 5.08%
5 Financials 5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LBRDA icon
26
Liberty Broadband Class A
LBRDA
$4.91B
$14.8M 1.38%
87,833
– –
NVRO
27
DELISTED
NEVRO CORP.
NVRO
$14.5M 1.35%
+87,200
New +$13.6M
HCA icon
28
HCA Healthcare
HCA
$87.2B
$14.2M 1.32%
68,613
-162,160
-70% -$33M
PVG
29
DELISTED
PRETIUM RESOURCES INC.
PVG
$13.4M 1.25%
1,406,412
– –
PSPC.U
30
DELISTED
Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant
PSPC.U
$13M 1.21%
+1,250,000
New +$12.6M
ZBH icon
31
Zimmer Biomet
ZBH
$18.2B
$12M 1.12%
76,910
-14,832
-16% -$2.4M
LIVN icon
32
LivaNova
LIVN
$4.43B
$10.6M 0.99%
+126,600
New +$10.4M
AVAN.U
33
DELISTED
Avanti Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
AVAN.U
$10.2M 0.95%
1,000,000
– –
DXCM icon
34
DexCom
DXCM
$32.3B
$9.37M 0.87%
87,812
+20,188
+30% +$1.94M
TGTX icon
35
TG Therapeutics
TGTX
$7.95B
$8.5M 0.79%
219,197
-37,700
-15% -$1.48M
QTRX icon
36
Quanterix
QTRX
$166M
$7.49M 0.7%
127,749
+50,500
+65% +$2.93M
APLS
37
DELISTED
Apellis Pharmaceuticals
APLS
$7.33M 0.68%
116,015
-207,985
-64% -$10.7M
CHFW.U
38
DELISTED
Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third
CHFW.U
$7.28M 0.68%
700,000
– –
NEXI
39
DELISTED
NexImmune, Inc. Common Stock
NEXI
$6.53M 0.61%
16,000
– –
ALEC icon
40
Alector
ALEC
$168M
$4.25M 0.4%
+203,900
New +$3.84M
SEER icon
41
Seer Inc
SEER
$120M
$1.89M 0.18%
+57,700
New +$2.28M
OLK
42
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$1.58M 0.15%
+45,925
New +$1.58M
NAUT icon
43
Nautilus Biotechnolgy
NAUT
$125M
$576K 0.05%
+57,000
New +$617K
MYPSW
44
DELISTED
PLAYSTUDIOS Inc Warrant
MYPSW
$261K 0.02%
141,105
-158,894
-53% -$279K
FCNCA icon
45
First Citizens BancShares
FCNCA
$24.9B
– –
-20,000
Closed -$16.7M
MSFT icon
46
Microsoft
MSFT
$3.43T
– –
-114,289
Closed -$26.9M
MYPS icon
47
PLAYSTUDIOS Inc
MYPS
$78.7M
– –
-899,997
Closed -$8.94M
DMTK
48
DELISTED
DermTech, Inc. Common Stock
DMTK
– –
-122,877
Closed -$6.24M
SQZ
49
DELISTED
SQZ Biotechnologies Company
SQZ
– –
-807,827
Closed -$9.96M
DRNA
50
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-588,910
Closed -$15.1M
1
2

Similar funds

SHFC
Safe Harbor Family Capital Chapel Hill, North Carolina $128M AUM
IUC
Ivory Union Consulting Road Town $128M AUM
PC
Pelham Capital London, United Kingdom $128M AUM 34.73% 1-Year Est. Return
SIM
Summitas Investment Management Mckinney, Texas $128M AUM
PIA
Prakash Investment Advisors Andover, Massachusetts $128M AUM 44.06% 1-Year Est. Return
S
Storgate Dallas, Texas $127M AUM
CF
Concorde Financial Dallas, Texas $127M AUM 24.97% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return

Bridger Management's Q2 2021 Portfolio in Review

As of Q2 2021, Bridger Management held 50 positions worth $1.07B, up 0.06% from $1.07B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Bridger Management withdrew a net $58.6M in Q2 2021, closing 6 positions and reducing 10 holdings. Its most notable exit was Microsoft, an estimated $26.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 40% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Bridger Management opened a new position in Centene worth $46M.

  • Bridger Management's largest Q2 2021 buy was Centene: 630,600 shares worth $46M.
  • Bridger Management added most to Clarivate in Q2 2021, an estimated $9.91M increase.
  • Bridger Management's biggest Q2 2021 reduction was HCA Healthcare, cutting an estimated $33M.
  • Bridger Management fully exited Microsoft in Q2 2021, selling an estimated $26.9M.
  • Bridger Management's ten largest holdings make up 49% of its $1.07B portfolio in Q2 2021.
  • Bridger Management opened 8 new positions and closed 6 in Q2 2021.
  • Bridger Management's portfolio value rose 0.06% quarter-over-quarter to $1.07B.

Based on Bridger Management's 13F filing for Q2 2021, filed 16 Aug 2021.